Temporary replacements for oral epilepsy treatments by Sisodiya, SM
 Temporary replacements for oral epilepsy treatment regimes 
 
One of the many potential challenges that may confront people with any chronic condition requiring 
regular medication is how to manage such medication during times of illness, especially if 
medication cannot be taken as usual. With epilepsy, there are additional complications that make 
such times particularly complicated: seizures may become more frequent during concurrent illness, 
other medications may interfere with antiepileptic drugs or may themselves cause seizures and 
seizures may directly impair recovery, for example, after some surgical procedures.  
The article by Banks et al. seeks to address one key issue in this setting – what to do with regular 
antiepileptic drugs for people who either cannot take their usual medication in tablet form, or those 
in whom absorption is compromised for any reason. The scenario is not uncommon – with over 16 
million admissions to hospital for some reason in 2015/2016 
(http://www.nhsconfed.org/resources/key-statistics-on-the-nhs, accessed 21.11.2016 ), many 
hospital admissions each year can be expected to occur in people with epilepsy for reasons other 
than their epilepsy, and a significant proportion are likely to require some adaptation to their home 
medication regime. However, as the authors point out, there is a lack of evidence upon which to 
base any strategy. 
These circumstances may occur by design, or unexpectedly. When there is time to plan, due 
consideration can be given to the particular changes that are likely to be needed. Specialist inpatient 
dental treatment is one example of such a situation. Proper advance consultation between the 
patient’s neurologist and the clinicians, including the anaesthetists if appropriate, involved in the 
admission can prevent undue distress. All concerned should be aware of the patient’s regular 
medication, potential interactions with other planned medications, including anaesthetic agents. It 
may be possible to undertake a procedure as a day case, and schedule the procedure to avoid the 
need to omit any medication. Rescue medication should be available in case seizures occur and 
require prompt control.  
In other situations, advance planning will not be possible. The suggestions provided by Banks et al. 
may then prove useful. The authors propose a series of options that might enable seizure control not 
to be disrupted. They rightly point out that perhaps the most useful action is to contact the patient’s 
usual neurologist – who will hopefully have a good knowledge of that patient’s epilepsy and its 
particular vagaries, of drugs that have been tried before and are prescribed currently, and of other 
individual circumstances to note. This will be especially important when the epilepsy has proven 
resistant to drug treatment, or when the patient may have a rare condition with which one cannot 
expect specialists in other fields to be familiar. Moreover, liaison between the patient’s regular 
neurologist and the admitting team, which may be based in another hospital, is especially important 
as a buffer between differing practices in different hospitals: for example, some formulations of 
some antiepileptic drugs may not be immediately available in every hospital. In the end, the 
guidelines from Banks et al. can only offer options, and individual strategies will be needed for each 
patient, making close liaison between the treating clinicians essential.     
Banks et al. offer suggestions for alternative formulations for a patient’s regular antiepileptic tablets 
or capsules. Local hospital formularies do vary, and actual stocks may not be available in a given 
hospital pharmacy. National variations also need to be borne in mind – for example, in the UK, 
carbamazepine suppositories are licensed, with dose and duration stipulations. Dose conversions 
between different formulations must be carefully considered and the advice of the hospital 
pharmacy should always be considered: the most up-to-date information should always be 
consulted. Particular care should be taken to avoid dosing errors, including dose miscalculations, in 
complex settings with unfamiliar drugs and uncommonly used formulations, especially for 
phenytoin. Banks et al. point out some potential pitfalls. One point to note is that recommendations 
in the UK are for the intravenous replacement dose of valproate to be the same as the established 
oral dose (BNF, accessed 21.11.2016).  
Rapid changes in an antiepileptic drug regime, in the context of an acute illness that may alter brain 
excitability and serum albumin levels, with co-prescription of other medications, may mandate 
measurement of serum drug levels, including those of the antiepileptic drugs. Taken in the context 
of the clinical picture, levels may help in determining the cause of unexpected clinical developments, 
such as altered conscious level or confusion and may guide dose adjustments. As Banks et al. point 
out, free levels may be to be requested.  
After the need for alternatives has passed, the patient will in most cases need to be returned to oral 
medication. Returning to the pre-existing regime may be the simplest option and will generally be 
possible, especially after shorter periods of altered treatment. Much longer periods may require one 
or more of the adaptations to be continued in addition to a regular home regime (which may itself 
be changed or unchanged). It is important in all cases to ensure that both GP and the regular 
treating neurologist are aware not only of the admission, but also of any changes made to treatment 
for the patient’s epilepsy.  
The article by Banks et al. brings to attention another difficult area in the management of epilepsy, 
and yet another area lacking good evidence. Considering the complexity and importance of the 
problem, the Epilepsy Advisory Group of the UK ABN will be issuing guidelines that may be useful to 
clinicians in this UK setting. Prospective collection of more information across the UK may further 
inform such advice, and might form part of an interesting and important clinical audit.  
